Healio

Tobramycin inhalation solution safe for bronchiectasis with Pseudomonas aeruginosa

Please provide your email address to receive an email when new articles are posted on . Tobramycin inhalation solution was effective in lowering bacterial density and positively influenced quality of ...
Medscape

FDA Panel Votes in Favor of Tobramycin Powder in Cystic Fibrosis

September 5, 2011 — In a 13-to-1 vote, a US Food and Drug Administration (FDA) advisory panel today said that evidence supports the safety and efficacy of tobramycin inhalation powder (TIP; TOBI ...
Medscape

Powder Tobramycin Okayed for Cystic Fibrosis Lung Infections

The US Food and Drug Administration (FDA) approved a tobramycin inhalation powder (TOBI Podhaler, Novartis) for treating patients with cystic fibrosis (CF) whose lungs are infected with the bacterium ...
Monthly Prescribing Reference

TOBI Podhaler Approved to Manage Cystic Fibrosis

TOBI Podhaler (tobramycin inhalation powder) 28mg capsules by Novartis Novartis' TOBI Podhaler, indicated for the management of cystic fibrosis in patients with Pseudomonas aeruginosa bacteria in the ...
FierceBiotech

Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden f

Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients CHMP supports approval of TOBI Podhaler, a ...
Business Insider

Dr. Reddy's Launches Tobramycin Inhalation Solution USP In U.S.

(RTTNews) - Integrated pharmaceutical company Dr. Reddy's Laboratories Ltd. (RDY) announced Tuesday the launch of Tobramycin Inhalation Solution, USP a therapeutic equivalent generic version of TOBI ...
Healio

FDA approves TOBI Podhaler for cystic fibrosis patients with infection

The FDA approved this week tobramycin inhalation powder for the management of Pseudomonas aeruginosa infection in patients with cystic fibrosis. The tobramycin inhalation powder (TOBI Podhaler, ...
Monthly Prescribing Reference

Kitabis Pak Access Now Expanded for Many States

Kitabis Pak (tobramycin inhalation solution) is now on the Preferred Drug List (PDL) for many state programs, expanding its access for patients with cystic fibrosis (CF) using nebulized antibiotic ...
FiercePharma

FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US

FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US - TOBI Podhaler is indicated for certain cystic fibrosis (CF) ...
Healthline

Dosage Details for Tobi (Tobramycin)

Tobi and Tobi Podhaler (tobramycin) are typically used twice per day for 4-week cycles (4 weeks on, 4 weeks off). It’s important to take the Tobi dosage your doctor prescribes. Tobi (tobramycin) is a ...
Business Wire

Dr. Reddy's Laboratories Announces the Launch of Tobramycin Inhalation Solution, USP in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...